galactosamine has been researched along with e 3330 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirota, K; Hishinuma, I; Katayama, K; Miyamoto, K; Nagakawa, J; Yamanaka, T; Yamatsu, I | 1 |
| Abe, S; Hirota, K; Hishinuma, I; Katayama, K; Miyamoto, K; Nagakawa, J; Yamanaka, T; Yamatsu, I | 1 |
| Hirota, K; Hishinuma, I; Katayama, K; Miyamoto, K; Nagakawa, J; Sonoda, J; Yamanaka, T; Yamatsu, I | 1 |
3 other study(ies) available for galactosamine and e 3330
| Article | Year |
|---|---|
Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-alpha-induced hepatitis in mice.
Topics: Animals; Ascitic Fluid; Benzoquinones; Chemical and Drug Induced Liver Injury; Dinoprostone; Galactosamine; In Vitro Techniques; Leukotriene B4; Male; Mice; Mice, Inbred C3H; Propionates; Rats; Thromboxane B2; Tumor Necrosis Factor-alpha | 1992 |
Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzoquinones; Endotoxins; Galactosamine; Hepatitis, Animal; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Propionates; Propionibacterium acnes; Tumor Necrosis Factor-alpha | 1992 |
Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
Topics: Animals; Benzoquinones; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endotoxins; Galactosamine; Lipopolysaccharides; Male; Propionates; Rats; Rats, Inbred F344 | 1993 |